Pathological consequences of systemic measles virus infection

Journal of Pathology

Volumn 235, Issue 2, 2015, Pages 253-265

  Ludlow, Martin ^a   McQuaid, Stephen ^b   Milner, Dan ^c   De Swart, Rik L D ^d,e   Duprex, W Paul ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Cell to cell spread; Central nervous system; Epithelium; Immune system; Measles virus

Indexed keywords

CD150 ANTIGEN; POLIOVIRUS RECEPTOR LIKE 4; UNCLASSIFIED DRUG; VIRUS RECEPTOR; MEASLES VACCINE;

ARTICLE; EPITHELIUM CELL; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOCOMPETENT CELL; LYMPHOID TISSUE; MEASLES; MEASLES VIRUS; NERVE CELL; NERVOUS TISSUE; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIMATE; PROTEIN EXPRESSION; RNA VIRUS; TISSUE SPECIFICITY; VACCINATION; VIRUS DETECTION; VIRUS PATHOGENESIS; VIRUS RECOMBINANT; VIRUS TRANSMISSION; ANIMAL; DISEASE MODEL; GENETICS; GENOTYPE; IMMUNOLOGY; MOLECULAR PATHOLOGY; PATHOGENICITY; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; TRANSMISSION; VIRAL TROPISM; VIROLOGY; VIRULENCE;

ANIMALS; DISEASE MODELS, ANIMAL; GENOTYPE; HOST-PATHOGEN INTERACTIONS; HUMANS; MEASLES; MEASLES VACCINE; MEASLES VIRUS; PATHOLOGY, MOLECULAR; PREDICTIVE VALUE OF TESTS; VIRAL TROPISM; VIROLOGY; VIRULENCE;

EID: 84917707333     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4457     Document Type: Article

References (125)

1. United Nations. The Millennium Development Report 2009. United Nations: New York, NY, 2009.
2. World Health Organization (WHO). Global Measles and Rubella Strategic Plan: 2012-2020. WHO: Geneva, 2012; 1-43.
3. Hirsch A. Handbook of Geographical and Historical Pathology: Acute Infective Diseases. New Syndenham Society: London, 1883.
4. Keeling MJ, Grenfell BT. Disease extinction and community size: modeling the persistence of measles. Science 1997; 275: 65-67.
5. Monto AS. Interrupting the transmission of respiratory tract infections: theory and practice. Clin Infect Dis 1999; 28: 200-204.
6. Anderson RM, May RM. Vaccination against rubella and measles: quantitative investigations of different policies. J Hyg (Lond) 1983; 90: 259-325.
7. Panum PL. Observations made during the epidempic of measles on the Faroe Islands in the year 1846. Med Classics 1939; 3: 839-886.
8. van Boven M, Kretzschmar M, Wallinga J, et al. Estimation of measles vaccine effcacy and critical vaccination coverage in a highly vaccinated population. J R Soc Interface 2010; 7: 1537-1544.
9. de Swart RL, Duprex WP, Osterhaus AD. Rinderpest eradication: lessons for measles eradication? Curr Opin Virol 2012; 2: 330-334.
10. OIE. Joint FAO/OIE Committee on Global Rinderpest Eradication. Final report May 2011: http://www.oie.int/fleadmin/Home/eng/Media-Center/docs/pdf/Final-Report-May2011.pdf
11. Drexler JF, Corman VM, Muller MA, et al. Bats host major mammalian paramyxoviruses. Nat Commun 2012; 3: 796.
12. Baron MD, Goatley L, Barrett T. Cloning and sequence analysis of the matrix (M) protein gene of rinderpest virus and evidence for another bovine morbillivirus. Virology 1994; 200: 121-129.
13. Keeling MJ. Modelling the persistence of measles. Trends Microbiol 1997; 5: 513-518.
14. Rima BK, Duprex WP. Morbilliviruses and human disease. J Pathol 2006; 208: 199-214.
15. Katz SL, Hinman AR. Summary and conclusions: measles elimination meeting, 16-17 March 2000. J Infect Dis 2004; 189(suppl 1): S43-47.
16. Centers for Disease Control (CDC). Measles cases and outbreaks: http://www.cdc.gov/measles/cases-outbreaks.html
17. ECDC. Surveillance report. Measles and Rubella Monitoring. April 2014: http://www.ecdc.europa.eu/en/publications/Publications/measles-rubella-monitoring-april-2014.pdf
18. Hall WC, Kovatch RM, Herman PH, et al. Pathology of measles in rhesus monkeys. Vet Pathol 1971; 8: 307-319.
19. MacArthur JA, Mann PG, Oreffo V, et al. Measles in monkeys: an epidemiological study. J Hyg (Lond) 1979; 83: 207-212.
20. van Binnendijk RS, van der Heijden RW, van Amerongen G, et al. Viral replication and development of specifc immunity in macaques after infection with different measles virus strains. J Infect Dis 1994; 170: 443-448.
21. McChesney MB, Miller CJ, Rota PA, et al. Experimental measles. I. Pathogenesis in the normal and the immunized host. Virol ogy 1997; 233: 74-84.
22. Zhu YD, Heath J, Collins J, et al. Experimental measles. II. Infection and immunity in the rhesus macaque. Virolo gy 1997; 233: 85-92.
23. Lemon K, de Vries RD, Mesman AW, et al. Early target cells of measles virus after aerosol infection of non-human primates. PLoS Pa t h o g 2011; 7: e1001263.
24. Takeuchi K, Takeda M, Miyajima N, et al. Stringent requirement for the C protein of wild-type measles virus for growth both in vitro and in macaques. J Virol 2005; 79: 7838-7844.
25. El Mubarak HS, Yuksel S, van Amerongen G, et al. Infection of cynomolgus macaques (Macaca fascicularis) and rhesus macaques (Macaca mulatta) with different wild-type measles viruses. J Gen Vi ro l 2007; 88: 2028-2034.
26. Ludlow M, de Vries RD, Lemon K, et al. Infection of lymphoid tissues in the macaque upper respiratory tract contributes to the emergence of transmissible measles virus. J Gen Virol 2013; 94: 1933-1944.
27. Ludlow M, Lemon K, de Vries RD, et al. Measles virus infection of epithelial cells in the macaque upper respiratory tract is mediated by subepithelial immune cells. J Virol 2013; 87: 4033-4042.
28. de Vries RD, McQuaid S, van Amerongen G, et al. Measles immune suppression: lessons from the macaque model. PLoS Pathog 2012; 8: e1002885.
29. Rima BK, Duprex WP. Molecular mechanisms of measles virus persistence. Vi r u s R e s 2005; 111: 132-147.
30. de Vries RD, Mesman AW, Geijtenbeek TB, et al. The pathogenesis of measles. Curr Opin Virol 2012; 2: 248-255.
31. Warthin AS. Occurrence of numerous large giant cells in the tonsils and pharyngeal mucosa in the prodromal stage of measles. Arch Pathol 1931; 11: 864-874.
32. Bunting CH. The giant-cells of measles. Yale J Biol Med 1950; 22: 513-519.
33. Finkeldey W. Über Riesenzellbefunde in den Gaumenmandeln, zugleich ein Beitrag zur Histopathologie der Mandelveränderungen im Maserninkubationsstadium. Virchows Arch 1931; 281: 323-329.
34. Stryker WA. Disseminated giant cell reaction a possible prodrome of measles. Am J Dis Child 59: 468-478.
35. Tatsuo H, Ono N, Tanaka K, et al. SLAM (CDw150) is a cellular receptor for measles virus. Nature 2000; 406: 893-897.
36. Calpe S, Wang N, Romero X, et al. The SLAM and SAP gene families control innate and adaptive immune responses. Adv Immunol 2008; 97: 177-250.
37. Kiel MJ, Yilmaz OH, Iwashita T, et al. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 2005; 121: 1109-1121.
38. Berger SB, Romero X, Ma C, et al. SLAM is a microbial sensor that regulates bacterial phagosome functions in macrophages. Nat Immunol 2010; 11: 920-927.
39. de Witte L, Abt M, Schneider-Schaulies S, et al. Measles virus targets DC-SIGN to enhance dendritic cell infection. J Virol 2006; 80: 3477-3486.
40. Ferreira CS, Frenzke M, Leonard VH, et al. Measles virus infection of alveolar macrophages and dendritic cells precedes spread to lymphatic organs in transgenic mice expressing human signaling lymphocytic activation molecule (SLAM, CD150). J Virol 2010; 84: 3033-3042.
41. Frenzke M, Sawatsky B, Wong XX, et al. Nectin-4-dependent measles virus spread to the cynomolgus monkey tracheal epithelium: role of infected immune cells infltrating the lamina propria. J Virol 2013; 87: 2526-2534.
42. Beineke A, Puff C, Seehusen F, et al. Pathogenesis and immunopathology of systemic and nervous canine distemper. Vet Immunol Immunopathol 2009; 127: 1-18.
43. Beckford AP, Kaschula RO, Stephen C. Factors associated with fatal cases of measles. A retrospective autopsy study. S Afr Med J 1985; 68: 858-863.
44. Akramuzzaman SM, Cutts FT, Wheeler JG, et al. Increased childhood morbidity after measles is short-term in urban Bangladesh. Am J Epidemiol 2000; 151: 723-735.
45. Rafat C, Klouche K, Ricard JD, et al. Severe measles infection: The spectrum of disease in 36 critically ill adult patients. Medicine (Baltimore) 2013; 92: e10-e18.
46. Shanks GD, Lee SE, Howard A, et al. Extreme mortality after frst introduction of measles virus to the polynesian island of Rotuma, 1911. Am J Epidemiol 2011; 173: 1211-1222.
47. Von Pirquet CE. Das Verhalten der kutanen Tuberkulin-reaktion während der Masern. Dtsch Med Wochenschr 1908; 34: 1297-1300.
48. Griffn DE, Ward BJ, Jauregui E, et al. Immune activation in measles. N Engl J Med 1989; 320: 1667-1672.
49. Mongkolsapaya J, Jaye A, Callan MF, et al. Antigen-specifc expansion of cytotoxic T lymphocytes in acute measles virus infection. J Virol 1999; 73: 67-71.
50. Schneider-Schaulies S, Schneider-Schaulies J. Measles virus-induced immunosuppression. Curr Top Microbiol Immunol 2009; 330: 243-269.
51. Hahm B. Hostile communication of measles virus with host innate immunity and dendritic cells. Curr Top Microbiol Immunol 2009; 330: 271-287.
52. Griffn DE. Measles virus-induced suppression of immune responses. Immunol Rev 2010; 236: 176-189.
53. + lymphocytes and dendritic cells during measles virus infection of macaques. PLoS Pathog 2007; 3: e178.
54. Noyce RS, Bondre DG, Ha MN, et al. Tumor cell marker PVRL4 (Nectin 4) is an epithelial cell receptor for measles virus. PLoS Pa t h o g 2011; 7: e1002240.
55. Muhlebach MD, Mateo M, Sinn PL, et al. Adherens junction protein nectin-4 is the epithelial receptor for measles virus. Nature 2011; 480: 530-533.
56. Reymond N, Fabre S, Lecocq E, et al. Nectin4/PRR4, a new afadin-associated member of the nectin family that trans-interacts with nectin1/PRR1 through V domain interaction. J Biol Chem 2001; 276: 43205-43215.
57. Noyce RS, Delpeut S, Richardson CD. Dog nectin-4 is an epithelial cell receptor for canine distemper virus that facilitates virus entry and syncytia formation. Virology 2013; 436: 210-220.
58. Birch J, Juleff N, Heaton MP, et al. Characterization of ovine Nectin-4, a novel peste des petits ruminants virus receptor. J Virol 2013; 87: 4756-4761.
59. Mandai K, Nakanishi H, Satoh A, et al. Afadin: A novel actin flament-binding protein with one PDZ domain localized at cadherin-based cell-to-cell adherens junction. J Cell Biol 1997; 139: 517-528.
60. Mandai K, Nakanishi H, Satoh A, et al. Ponsin/SH3P12: an l-afadin-and vinculin-binding protein localized at cell-cell and cell-matrix adherens junctions. J Cell Biol 1999; 144: 1001-1017.
61. Brancati F, Fortugno P, Bottillo I, et al. Mutations in PVRL4, encoding cell adhesion molecule nectin-4, cause ectodermal dysplasia-syndactyly syndrome. Am J Hum Genet 2010; 87: 265-273.
62. Takano A, Ishikawa N, Nishino R, et al. Identifcation of nectin-4 oncoprotein as a diagnostic and therapeutic target for lung cancer. Cancer Res 2009; 69: 6694-6703.
63. Nabih ES, Abdel Motaleb FI, Salama FA. The diagnostic effcacy of nectin 4 expression in ovarian cancer patients. Biomarkers 2014; 19: 1-7.
64. Derycke MS, Pambuccian SE, Gilks CB, et al. Nectin 4 overexpres-sion in ovarian cancer tissues and serum: potential role as a serum biomarker. Am J Clin Pathol 2010; 134: 835-845.
65. Fabre-Lafay S, Garrido-Urbani S, Reymond N, et al. Nectin-4, a new serological breast cancer marker, is a substrate for tumor necrosis factor-α-converting enzyme (TACE)/ADAM-17. J Biol Chem 2005; 280: 19543-19550.
66. Pavlova NN, Pallasch C, Elia AE, et al. A role for PVRL4-driven cell-cell interactions in tumorigenesis. Elife 2013; 2: e00358.
67. Mateo M, Navaratnarajah CK, Syed S, et al. The measles virus hemagglutinin β-propeller head β4-β5 hydrophobic groove governs functional interactions with nectin-4 and CD46 but not those with the signaling lymphocytic activation molecule. J Virol 2013; 87: 9208-9216.
68. Delpeut S, Noyce RS, Richardson CD. The V domain of dog PVRL4 (nectin-4) mediates canine distemper virus entry and virus cell-to-cell spread. Virology 2014; 454-455: 109-117.
69. Katayama Y, Hotta H, Nishimura A, et al. Detection of measles virus nucleoprotein mRNA in autopsied brain tissues. J Gen Virol 1995; 76: 3201-3204.
70. Katayama Y, Kohso K, Nishimura A, et al. Detection of measles virus mRNA from autopsied human tissues. J Clin Microbiol 1998; 36: 299-301.
71. Gibbs EL, Grossman HJ, Spies HW. Electroencephalographic studies on children having measles with no clinical evidence of involvement of the central nervous system. Pediatrics 1956; 18: 556-560.
72. Fisher DL, Defres S, Solomon T. Measles-induced encephalitis. Qu J Med 2014; DOI: 10.1093/qjmed/hcu113.
73. Buchanan R, Bonthius DJ. Measles virus and associated central nervous system sequelae. Semin Pediatr Neurol 2012; 19: 107-114.
74. Javed A, Khan O. Acute disseminated encephalomyelitis. Handb Clin Neurol 2014; 123: 705-717.
75. Elhassanien AF, Aziz HA. Acute demyelinating encephalomyelitis: clinical characteristics and outcome. J Pediatr Neurosci 2013; 8: 26-30.
76. Mohsen H, Abu Zeinah GF, Elsotouhy AH, et al. Acute disseminated encephalomyelitis following infectious mononucleosis in a toddler. BMJ Case Rep 2013; DOI: 10.1136/bcr-2013-010048.
77. Miller HG, Stanton JB, Gibbons JL. Acute disseminated encephalomyelitis and related syndromes. Br Med J 1957; 1: 668-672.
78. Johnson RT, Griffn DE, Hirsch RL, et al. Measles encephalomyeli-tis-clinical and immunologic studies. N Engl J Med 1984; 310: 137-141.
79. Nardone R, Golaszewski S, Trinka E, et al. Acute disseminated encephalomyelitis preceding measles exanthema. J Child Neurol 2011; 26: 1590-1592.
80. Mustafa MM, Weitman SD, Winick NJ, et al. Subacute measles encephalitis in the young immunocompromised host: report of two cases diagnosed by polymerase chain reaction and treated with ribavirin and review of the literature. Clin Infect Dis 1993; 16: 654-660.
81. Agamanolis DP, Tan JS, Parker DL. Immunosuppressive measles encephalitis in a patient with a renal transplant. Arch Neurol 1979; 36: 686-690.
82. Aicardi J, Goutieres F, Arsenio-Nunes ML, et al. Acute measles encephalitis in children with immunosuppression. Pediatrics 1977; 59: 232-239.
83. Hardie DR, Albertyn C, Heckmann JM, et al. Molecular characterisation of virus in the brains of patients with measles inclusion body encephalitis (MIBE). Vi ro l J 2013; 10: 283.
84. Freeman AF, Jacobsohn DA, Shulman ST, et al. A new complication of stem cell transplantation: measles inclusion body encephalitis. Pediatrics 2004; 114: e657-660.
85. Bitnun A, Shannon P, Durward A, et al. Measles inclusion-body encephalitis caused by the vaccine strain of measles virus. Clin Infect Dis 1999; 29: 855-861.
86. Spalke G, Eschenbach C. Infantile cortical measles inclusion body encephalitis during combined treatment of acute lymphoblastic leukemia. J Neurol 1979; 220: 269-277.
87. Greenfeld JG. Encephalitis and encephalomyelitis in England and Wales during the last decade. Brain 1950; 73: 141-166.
88. Connolly JH, Allen IV, Hurwitz LJ, et al. Measles-virus antibody and antigen in subacute sclerosing panencephalitis. Lancet 1967; 1: 542-544.
89. Gagnon A, Bouchard RW. Fulminating adult-onset subacute scle-rosing panencephalitis in a 49 year-old man. Arch Neurol 2003; 60: 1160-1161.
90. Freeman JM. The clinical spectrum and early diagnosis of Dawson's encephalitis, with preliminary notes on treatment. J Pediatr 1969; 75: 590-603.
91. Connolly JH, Allen IV, Hurwitz LJ, et al. Subacute sclerosing panencephalitis. Clinical, pathological, epidemiological, and viro-logical fndings in three patients. Qu J Med 1968; 37: 625-644.
92. Miller C, Farrington CP, Harbert K. The epidemiology of subacute sclerosing panencephalitis in England and Wales 1970-1989. Int J Epidemiol 1992; 21: 998-1006.
93. Tan E, Namer IJ, Ciger A, et al. The prognosis of subacute scleros-ing panencephalitis in adults. Report of 8 cases and review of the literature. Clin Neurol Neurosurg 1991; 93: 205-209.
94. Mahadevan A, Vaidya SR, Wairagkar NS, et al. Case of fulminant-SSPE associated with measles genotype D7 from India: an autopsy study. Neuropathology 2008: 28: 621-626.
95. Bellini WJ, Rota JS, Lowe LE, et al. Subacute sclerosing panen-cephalitis: more cases of this fatal disease are prevented by measles immunization than was previously recognized. J Infect Dis 2005; 192: 1686-1693.
96. Manning L, Laman M, Edoni H, et al. Subacute sclerosing panen-cephalitis in papua new guinean children: the cost of continuing inadequate measles vaccine coverage. PLoS Negl Trop Dis 2011; 5: e932.
97. Takasu T, Mgone JM, Mgone CS, et al. A continuing high incidence of subacute sclerosing panencephalitis (SSPE) in the Eastern Highlands of Papua New Guinea. Epidemiol Infect 2003; 131: 887-898.
98. Schonberger K, Ludwig MS, Wildner M, et al. Epidemiology of subacute sclerosing panencephalitis (SSPE) in Germany from 2003 to 2009: a risk estimation. PLoS One 2013; 8: e68909.
99. Dawson JR. Cellular inclusions in cerebral lesions of lethargic encephalitis. Am J Pathol 1933; 9: 7-16.
100. Dawson JR. Cellular inclusions in cerebral lesions of epidemic encephalitis, second report. Arch Neur Psych 1934; 31: 685-700.
101. Bouteille M, Fontaine C, Vedrenne CL, et al. Sur un cas d'encephalite subaigue a inclusions. Étude anatomclinique et ultrastructurelle. Rev Neurol (Paris) 1965; 118: 454-458.
102. Cattaneo R, Schmid A, Rebmann G, et al. Accumulated measles virus mutations in a case of subacute sclerosing panencephalitis: interrupted matrix protein reading frame and transcription alteration. Virology 1986; 154: 97-107.
103. Cattaneo R, Schmid A, Eschle D, et al. Biased hypermutation and other genetic changes in defective measles viruses in human brain infections. Cell 1988; 55: 255-265.
104. Cattaneo R, Schmid A, Spielhofer P, et al. Mutated and hypermu-tated genes of persistent measles viruses which caused lethal human brain diseases. Virology 1989; 173: 415-425.
105. Schmid A, Spielhofer P, Cattaneo R, et al. Subacute sclerosing panencephalitis is typically characterized by alterations in the fusion protein cytoplasmic domain of the persisting measles virus. Virology 1992; 188: 910-915.
106. Herndon RM, Rubinstein LJ. Light and electron microscopy observations on the development of viral particles in the inclusions of Dawson's encephalitis (subacute sclerosing panencephalitis). Neurology 1968; 18: 8-20.
107. Brown HR, Goller NL, Rudelli RD, et al. Postmortem detection of measles virus in non-neural tissues in subacute sclerosing panen-cephalitis. Ann Neurol 1989; 26: 263-268.
108. Fournier JG, Tardieu M, Lebon P, et al. Detection of measles virus RNA in lymphocytes from peripheral-blood and brain perivascu-lar infltrates of patients with subacute sclerosing panencephalitis. N Engl J Med 1985; 313: 910-915.
109. Fournier JG, Gerfaux J, Joret AM, et al. Subacute sclerosing panen-cephalitis: detection of measles virus sequences in RNA extracted from circulating lymphocytes. Br Med J (Clin Res Ed) 1988; 296: 684.
110. Kirk J, Zhou AL, McQuaid S, et al. Cerebral endothelial cell infection by measles virus in subacute sclerosing panencephalitis: ultrastructural and in situ hybridization evidence. Neuropathol Appl Neu-robiol 1991; 17: 289-297.
111. McQuaid S, Kirk J, Zhou AL, et al. Measles virus infection of cells in perivascular infltrates in the brain in subacute sclerosing panen-cephalitis: confrmation by non-radioactive in situ hybridization, immunocytochemistry and electron microscopy. Acta Neuropathol 1993; 85: 154-158.
112. McQuaid S, Cosby SL. An immunohistochemical study of the distribution of the measles virus receptors, CD46 and SLAM, in normal human tissues and subacute sclerosing panencephalitis. Lab Invest 2002; 82: 403-409.
113. Allen IV, McQuaid S, McMahon J, et al. The signifcance of measles virus antigen and genome distribution in the CNS in SSPE for mechanisms of viral spread and demyelination. J Neuropathol Exp Neurol 1996; 55: 471-480.
114. Isaacson SH, Asher DM, Godec MS, et al. Widespread, restricted low-level measles virus infection of brain in a case of subacute sclerosing panencephalitis. Acta Neuropathol 1996; 91: 135-139.
115. Iwasaki Y, Koprowski H. Cell-to-cell transmission of virus in the central nervous system. I. Subacute sclerosing panencephalitis. Lab Invest 1974; 31: 187-196.
116. Seki F, Yamada K, Nakatsu Y, et al. The SI strain of measles virus ferived from a patient with subacute scleorosing panencephalitis possesses typical genome alterations and unique amino acid changes that modulate receptor specifcity and reduce membrane fusion activity. J Virol 2011; 85: 11871-11882.
117. Mesquita R, Castanos-Velez E, Biberfeld P, et al. Measles virus antigen in macrophage/microglial cells and astrocytes of subacute sclerosing panencephalitis. Acta Pathol Microbiol Immunol Scand 1998; 106: 553-561.
118. Kumanishi T, In S. SSPE: immunohistochemical demonstration of measles virus antigen(s) in paraffn sections. Acta Neuropathol 1979; 48: 161-163.
119. Paula-Barbosa MM, Cruz C. Nerve cell fusion in a case of subacute sclerosing panencephalitis. Ann Neurol 1981; 9: 400-403.
120. Esiri MM, Oppenheimer DR, Brownell B, et al. Distribution of measles antigen and immunoglobulin-containing cells in the CNS in subacute sclerosing panencephalitis (SSPE) and atypical measles encephalitis. J Neurol Sci 1982; 53: 29-43.
121. Naniche D, Varior-Krishnan G, Cervoni F, et al. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J Virol 1993; 67: 6025-6032.
122. Dörig RE, Marcil A, Chopra A, et al. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 1993; 75: 295-305.
123. Escriou N, Callendret B, Lorin V, et al. Protection from SARS coronavirus conferred by live measles vaccine expressing the spike glycoprotein. Virology 2014; 452-453: 32-41.
124. Brandler S, Ruffe C, Najburg V, et al. Pediatric measles vaccine expressing a dengue tetravalent antigen elicits neutralizing antibodies against all four dengue viruses. Vaccine 2010; 28: 6730-6739.
125. De Vries R, de Swart RL. Measles immune suppression: functional impairment or numbers game. PLoS Pathog, doi: 10.1371/journal. ppat.1004482 (in press).